Integrating smoking cessation and alcohol use treatment in homeless populations: study protocol for a randomized controlled trial

Trials
Olamide Ojo-FatiKolawole S Okuyemi

Abstract

Despite progress in reducing cigarette smoking in the general U.S. population, smoking rates, cancer morbidity and related heart disease remain strikingly high among the poor and underserved. Homeless individuals' cigarette smoking rate remains an alarming 70% or greater, and this population is generally untreated with smoking cessation interventions. Furthermore, the majority of homeless smokers also abuse alcohol and other drugs, which makes quitting more difficult and magnifies the health consequences of tobacco use. Participants will be randomized to one of three groups, including (1) an integrated intensive smoking plus alcohol intervention using cognitive behavioral therapy (CBT), (2) intensive smoking intervention using CBT or (3) usual care (i.e., brief smoking cessation and brief alcohol counseling). All participants will receive 12-week treatment with a nicotine patch plus nicotine gum or lozenge. Counseling will include weekly individual sessions for 3 months, followed by monthly booster group sessions for 3 months. The primary smoking outcome is cotinine-verified 7-day smoking abstinence at follow-up week 52, and the primary alcohol outcome will be breathalyzer-verified 90-day alcohol abstinence at week 52. This stu...Continue Reading

Associated Clinical Trials

References

Sep 1, 1992·Clinical Pharmacokinetics·N G Schneider
May 1, 1992·Journal of General Internal Medicine·G S Ferenchick
Jan 1, 1988·Addictive Behaviors·T A Burling, D C Ziff
Aug 4, 1994·The New England Journal of Medicine·J R HibbsD K Fife
Mar 1, 1993·Journal of Substance Abuse Treatment·K L Sees, H W Clark
Feb 1, 1997·Journal of Health Care for the Poor and Underserved·M R Cousineau
Jun 12, 1998·The New England Journal of Medicine·S A SalitA L Mosso
Jul 17, 1998·Archives of Internal Medicine·S W HwangT A Brennan
Apr 7, 1999·American Journal of Public Health·S M BarrowE L Struening
Jul 27, 1999·International Journal of Cancer. Journal International Du Cancer·X CastellsaguéM J Quintana
Dec 3, 1999·Journal of Health Care for the Poor and Underserved·N Sachs-EricssonH B Paniucki
May 3, 2000·JAMA : the Journal of the American Medical Association·S W Hwang
May 17, 2000·Drug and Alcohol Dependence·D A Dawson
Jun 6, 2002·Journal of General Internal Medicine·Sharon E ConnorJennifer T Williams
Mar 11, 2004·JAMA : the Journal of the American Medical Association·Ali H MokdadJulie L Gerberding
Mar 1, 2006·Preventive Medicine·Arnaud ChioleroJacques Cornuz
Apr 11, 2007·Archives of Internal Medicine·Sherry A McKeePatrick G O'Connor
Sep 19, 2007·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Ned L CooneyCheryl A Oncken
Dec 13, 2007·Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors·Ned L CooneyCheryl A Oncken
Dec 6, 2008·Drug and Alcohol Dependence·Christopher W KahlerK Michael Cummings
Jun 9, 2010·American Journal of Health Behavior·Donna ShelleyDoug Warn
Jan 15, 2011·American Journal of Public Health·Bonnie D KerkerLorna E Thorpe
May 31, 2011·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Iris TorchallaMichael Krausz
Dec 15, 2011·Clinical Trials : Journal of the Society for Clinical Trials·Kate GoldadeKolawole S Okuyemi
May 17, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Kolawole S OkuyemiDon Des Jarlais
Dec 18, 2013·Addictive Behaviors·Nadra E LishaKevin L Delucchi

❮ Previous
Next ❯

Citations

Jun 6, 2019·The Cochrane Database of Systematic Reviews·Jamie Hartmann-BoyceThomas R Fanshawe
Oct 14, 2016·International Journal of Environmental Research and Public Health·Sharon Lawn, Teri Lucas
Sep 30, 2019·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Rebekah PrattAnne Joseph
Dec 8, 2020·The Cochrane Database of Systematic Reviews·Maya VijayaraghavanDorie Apollonio

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Clinical Trials Mentioned

NCT01932996

Software Mentioned

REDCap

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors
Ned L CooneyCheryl A Oncken
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
Kolawole S OkuyemiDon Des Jarlais
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco
Kolawole S OkuyemiJasjit S Ahluwalia
© 2021 Meta ULC. All rights reserved